Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Parkinson's Progression Markers Initiative (PPMI) Clinical - Establishing a Deeply Phenotyped PD Cohort

NCT04477785 is registered in ClinicalTrials.gov with Michael J. Fox Foundation for Parkinson's Research as lead sponsor.

NCT NCT04477785
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04477785 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Parkinson's Progression Markers Initiative (PPMI) Clinical - Establishing a Deeply Phenotyped PD Cohort
Lead sponsor
Michael J. Fox Foundation for Parkinson's Research
Phase
Observational
Overall status
Recruiting
Start date
July 1, 2020
Completion date
December 31, 2033
Enrollment
4,500 (estimated)
Sites
50

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson disease